Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cost of Revenue: 2019-2024

Historic Cost of Revenue for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $156.8 million.

  • Harmony Biosciences Holdings' Cost of Revenue rose 39.44% to $59.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.2 million, marking a year-over-year increase of 26.55%. This contributed to the annual value of $156.8 million for FY2024, which is 29.35% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Cost of Revenue of $156.8 million as of FY2024, which was up 29.35% from $121.2 million recorded in FY2023.
  • Harmony Biosciences Holdings' 5-year Cost of Revenue high stood at $156.8 million for FY2024, and its period low was $55.8 million during FY2020.
  • Over the past 3 years, Harmony Biosciences Holdings' median Cost of Revenue value was $121.2 million (recorded in 2023), while the average stood at $120.5 million.
  • Data for Harmony Biosciences Holdings' Cost of Revenue shows a peak YoY surged of 45.23% (in 2023) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Cost of Revenue (Yearly) stood at $55.8 million in 2020, then rose by 22.02% to $68.1 million in 2021, then increased by 22.55% to $83.5 million in 2022, then spiked by 45.23% to $121.2 million in 2023, then increased by 29.35% to $156.8 million in 2024.